Prosight Management’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-470,000
Closed -$9.7M 51
2024
Q1
$9.7M Buy
+470,000
New +$10.1M 2.7% 12
2019
Q4
Sell
-41,700
Closed -$2.66M 41
2019
Q3
$2.66M Buy
+41,700
New +$3.67M 1.48% 23

Other funds holding GH

Prosight Management's GH Position: Q2 2024 in Review

Prosight Management sold out of Guardant Health (GH) in Q2 2024, closing a stake of 470,000 shares — an estimated $9.7M sold.

Prosight Management first reported a position in GH in Q3 2019 and held it in 2 quarters. The position peaked at $9.7M in Q1 2024. 282 funds tracked by Wall St. Rank hold GH as of Q2 2024.

  • Prosight Management reported no remaining Guardant Health position as of Q2 2024 after selling out during the quarter.
  • Prosight Management sold 470,000 Guardant Health shares in Q2 2024, an estimated $9.7M.
  • Prosight Management first reported a position in Guardant Health in Q3 2019 and held it in 2 quarters.
  • Prosight Management's Guardant Health position peaked at $9.7M in Q1 2024.
  • 282 funds tracked by Wall St. Rank held Guardant Health as of Q2 2024.

Based on Prosight Management's 13F filing for Q2 2024, filed 14 Aug 2024.